30.65
0.00%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About A-Spine Asia Co
Its shares trade on Taipei Exchange under the ticker 6758.TWO. It has been listed since 2 January 2020. In the fiscal year to 31 December 2025, it reported revenue of TWD 448.8m and net income of TWD 15.1m. At that date it held total assets of TWD 519.5m and shareholders' equity of TWD 274.4m.
A-Spine Asia Co., Ltd. is an medical device company which engages in the research, development, design, manufacture and marketing of spinal implants for better spine health management. The company is headquartered in Taipei, New Taipei. The company went IPO on 2020-01-02. The firm is engaged in the provision of spine fixation system, spinal fusion system, vertebral body replacement system and bone filling system products. The spinal fixation system includes WinLoc II, CervoLoc, SmartLoc, SmartMIS, PACH and other products, used for spinal fixation and thoracolumbar fixation. The spinal fusion system includes products such as Combo cervical and lumbar intervertebral disc fusion devices, used for spinal reconstruction surgery. The vertebral body replacement system includes products such as A-Mesh titanium mesh, used to provide stable support for vertebral body. The bone filling system includes products such as Avalon vertebral expander, used for intervertebral distraction.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 2 Jan 2020
- Website
- aspine.com.tw ↗
Leadership
Pay as last reported
- Yansheng LinChairman of the Board, since 2020
- Haojuan XueGeneral Manager
- Weizhan LiaoHead of Finance & Accounting, Corporate Governance Officer
- Jianzhong LiaoDirector
- Yuwei LinDirector
- Zaijiu YuDirector
- Shengwen CaiIndependent Director
- Mr. Shihan HuangIndependent Director
- Ms. Ming-Hsuan LiIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- A-Spine Asia's WinLoc II spinal fixation system is a key product in the spinal implant market.
- The company's spinal fusion system includes Combo cervical and lumbar intervertebral disc fusion devices.
- A-Mesh titanium mesh is a leading vertebral body replacement system for spinal support.
Weaknesses
- The company's products are limited to spinal implant systems without broader medical device diversification.
- A-Spine Asia has no presence in the European market despite global medical device trends.
- The firm's IPO in 2020 shows limited market expansion since listing.
Opportunities
- Expanding into the U.S. spinal implant market could leverage A-Spine Asia's product portfolio.
- Growing demand for spinal fusion systems in Asia presents a significant opportunity.
- Increasing adoption of vertebral body replacement systems in emerging markets is promising.
Threats
- Competition from established spinal implant manufacturers in the U.S. market.
- Regulatory changes in Taiwan could impact the company's manufacturing operations.
- Economic downturns in Asia may reduce healthcare spending on spinal implants.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.